Phase III randomized, placebo-controlled trial of docetaxel with or without gefitinib in recurrent or metastatic head and neck cancer: An eastern cooperative oncology group trial
Athanassios Argiris, Musie Ghebremichael, Jill Gilbert, Ju Whei Lee, Kamakshi Sachidanandam, Jill M. Kolesar, Barbara Burtness, Arlene A. Forastiere
Fingerprint
Dive into the research topics of 'Phase III randomized, placebo-controlled trial of docetaxel with or without gefitinib in recurrent or metastatic head and neck cancer: An eastern cooperative oncology group trial'. Together they form a unique fingerprint.